Odey Holdings (Switzerland)’s Regeneron Pharmaceuticals REGN Stock Holding History

Odey Holdings (Switzerland)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$520K	Hold	1,100	–	–	4.68%	9
2020 Q4	$531K	Buy	1,100 +150	+16%	+$81K	5.47%	8
2020 Q3	$532K	Hold	950	–	–	4.63%	5
2020 Q2	$592K	Sell	950 -190	-17%	-$108K	6.31%	4
2020 Q1	$557K	Buy	+1,140	New	+$470K	6.8%	4
2019 Q3	–	Sell	-430	Closed	-$135K	–	17
2019 Q2	$135K	Buy	430 +290	+207%	+$96.5K	1.72%	14
2019 Q1	$57K	Sell	140 -100	-42%	-$41.2K	0.71%	13
2018 Q4	$90K	Hold	240	–	–	6.29%	2
2018 Q3	$97K	Hold	240	–	–	5.18%	6
2018 Q2	$83K	Buy	240 +92	+62%	+$28.8K	5.42%	4
2018 Q1	$51K	Hold	148	–	–	4.03%	11
2017 Q4	$56K	Hold	148	–	–	3.42%	10
2017 Q3	$66K	Hold	148	–	–	4.33%	10
2017 Q2	$73K	Buy	148 +74	+100%	+$32.4K	5.27%	7
2017 Q1	$29K	Sell	74 -20	-21%	-$7.41K	2.49%	17
2016 Q4	$35K	Sell	94 -46	-33%	-$17.5K	2.27%	18
2016 Q3	$56K	Sell	140 -100	-42%	-$40.1K	2.44%	19
2016 Q2	$84K	Buy	240 +67	+39%	+$25.8K	3.62%	14
2016 Q1	$62K	Buy	+173	New	+$71.3K	1.08%	22

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Odey Holdings (Switzerland)'s REGN Position: Q1 2021 in Review

Odey Holdings (Switzerland) held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2021 at 1,100 shares worth $520K. The position accounts for 4.68% of the portfolio, ranked #9.

Odey Holdings (Switzerland) first reported a position in REGN in Q1 2016 and has held it in 19 quarters since. The position peaked at $592K in Q2 2020. 925 funds tracked by Wall St. Rank hold REGN as of Q1 2021.

Odey Holdings (Switzerland) held 1,100 shares of Regeneron Pharmaceuticals worth $520K as of Q1 2021.
Odey Holdings (Switzerland) left its Regeneron Pharmaceuticals share count unchanged in Q1 2021.
Regeneron Pharmaceuticals made up 4.68% of Odey Holdings (Switzerland)'s portfolio in Q1 2021, its #9 holding.
Odey Holdings (Switzerland) first reported a position in Regeneron Pharmaceuticals in Q1 2016 and has held it in 19 quarters since.
Odey Holdings (Switzerland)'s Regeneron Pharmaceuticals position peaked at $592K in Q2 2020.
925 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2021.

Based on Odey Holdings (Switzerland)'s 13F filing for Q1 2021, filed 17 May 2021.